Skip to main content
BMC Medical Genomics logoLink to BMC Medical Genomics
. 2023 Jun 16;16:136. doi: 10.1186/s12920-023-01578-9

Correction: Glycosyltransferase GLT8D1 and GLT8D2 serve as potential prognostic biomarkers correlated with Tumor Immunity in Gastric Cancer

Huimei Xu 1,2,#, Ke Huang 3,#, Yimin Lin 1,2, Hang Gong 1,2, Xueni Ma 1,2, Dekui Zhang 2,4,
PMCID: PMC10273608  PMID: 37328741

Correction: BMC Med Genomics 16, 123 (2023)

10.1186/s12920-023-01559-y

Following publication of the original article [1], the authors reported errors in the numbering of the in-text citations from number 16 onwards. The original article [1] has been corrected.

Footnotes

The online version of the original article can be found at 10.1186/s12920-023-01559-y.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Huimei Xu, Ke Huang contributed equally to this work.

References

  • 1.Xu H, Huang K, Lin Y, et al. Glycosyltransferase GLT8D1 and GLT8D2 serve as potential prognostic biomarkers correlated with Tumor Immunity in Gastric Cancer. BMC Med Genomics. 2023;16:123. doi: 10.1186/s12920-023-01559-y. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMC Medical Genomics are provided here courtesy of BMC

RESOURCES